Recent studies have clearly identified that hematopoietic stem cells (HSC) are part of a hierarchical organization defined by cells able to initiate long-term repopulation (LT-HSC) of injured BM followed by populations with transient repopulation ability. As HSCs are able to supply blood cells for the lifespan of the individual, LT-HSCs undergo an aging process. The consequences of aging are an increase in the stem cell pool size, increased selfrenewal and production of cells with expression of myeloid-specific genes and genes commonly expressed in myeloid leukemia. The age-related increased incidence of myeloproliferative disorders is therefore not surprising. Marrow cells circulate and migrate to a number of different organs. Previously assumed tissue and organ specificities appear to be less stringent and primitive cells residing in one organ may contribute to the structural and functional regeneration of other organs. It is intriguing to speculate that cells and cytokines used in appropriate concentrations may be able to repair damaged organs by using the defective organ as a scaffold, thus reducing the need for the transplantation of solid organs. 
2 An early transition is defined by the acquisition of CD34 positivity followed by expression of lineage-specific markers. 3 Although HSCs are able to supply blood cells for the lifespan of the individual, LT-HSCs undergo an aging process. 4 Microarray analysis of purified LT-HSCs isolated from young and old mice demonstrated significant changes in their gene expression profile. 2 Nine hundred and seven out of 34 000 genes were found to be age regulated including genes that are responsible for lymphoid and myeloid function. For instance, lymphoid properties such as expression of the IL-2 receptor gene, IL 7R expression, FMS-like tyrosine kinase and C-srk tyrosine kinase expression are downregulated. In contrast, myeloid-related genes such as PML, AML1/Runx1, ETO/Cbfa211h are upregulated. The consequences of HSC aging shows an increase in the stem cell pool size, increased self-renewal and production of cells with expression of myeloid-specific genes and genes commonly expressed in myeloid leukemia. The age-related increased incidence of myeloproliferative disorders is therefore not surprising. The decreased frequency of lymphoid progenitor cells and reduced expression of lymphoid-specific genes are associated with deteriorating function of the adaptive immune system. Hematopoietic stem cells have the ability to circulate and to home to tissue-specific structures. These processes are regulated by a number of events including change from a free intravascular flow of the cells to a rolling action along the wall of blood vessels, adherence to the vascular endothelium, egress through the vessel wall and finally homing to a stromal structure. [5] [6] [7] [8] [9] [10] The event is predominantly the function of an interaction between SDF-1 and its receptor CXCR4. SDF-1 is excreted by BM and binds exclusively to CXCR4 expressed on the surface of hematopoietic progenitors as well as other cell types. CXCR4 expression is regulated by a number of factors, which include transcription factors of the PAX family that may regulate CXCR4 expression in a tissue-specific manner. 11, 12 For instance, PAX1 influences osteoblastic SC, whereas PAX5 seems to direct B-cell lymphocytic progenitors. Other components such as nuclear factor-kB, IFN-a, VEGF, IFN-a and the cytokines IL2, 4 and 7 play an additional role. cancer stem cells including breast cancer, ovarian cancer, prostate cancer, neuroblastoma and rhabdomyosarcoma. [13] [14] [15] [16] [17] It is therefore likely that a similar regulatory principle as it is operative in homing of HSCs might be employed by cancer cells as part of their metastatic potential.
The ability of marrow cells to circulate facilitates their migration to a number of different organs. This phenomenon was originally observed in marrow transplant recipients. Cells of donor origin can be observed in the form of hepatocytes, cholangiocytes, cardiomyocytes, Purkinje cells, epidermal cells and intestinal endothelial cells. Similarly, cells from recipients of solid organs may travel and become integrated into the transplanted organ. 18, 19 These observations have fostered the hypothesis that BM may contain in addition to hematopoietic cells, also other tissue-specific stem cells. There are any number of possibilities to explain the phenomenon. The production of cells with different organ specificity may result from a common primordial stem cell. Alternatively, marrow may house tissue-specific stem cells for different organs or as suggested HSCs may display flexibility in their differentiation and de-differentiation potential. Certainly, cells isolated from marrow or peripheral blood may express markers for skeletal muscle, heart muscle, neural tissue, liver and endocrine pancreas. In addition to the expression of specific markers, culture studies have shown that these cells may acquire organ-specific functions when exposed to appropriate conditions. For instance, they may develop into neurospheres, cardiomyocytes, hepatocytes endocrine pancreatic cells and endothelial cells.
A reason to migrate may be injury to various tissues. This has been well demonstrated in animal studies describing the migration of neural stem cells to areas of tissue damage in the brain. 20, 21 The anatomic repair process including functional improvement is enhanced through the administration of cytokines, such as EGF and EPO. This model system shows an elegant approach to capitalize on organ repair based on utilizing endogenous organ-specific stem cells rather than transplanted cells.
Similar approaches are being tested clinically. For instance, the question is raised whether or not endogenous expansion and mobilization of HSC by G-CSF may result in benefit for patients with cardiac injuries. This strategy and re-infusion of HSC will require further testing and refinement.
Conclusion
Technology is now available to identify, isolate and propagate cells with stem cell function and regenerative capacity. Previously assumed tissue and organ specificities appear to be less stringent and primitive cells residing in one organ may contribute to the structural and functional regeneration of other organs. It is not clear whether this process involves primordial stems cells that may reside in different organs or whether stem cells of one organ may redirect their differentiation potential. It is also not clear whether or not the observed plasticity is a true function of stem cells or may represent fusion events between cell types of different origin. It is intriguing to speculate that cells and cytokines used in appropriate concentrations may be able to repair damaged organs by using the defective organ as a scaffold, thus reducing the need for the transplantation of solid organs.
